Abstract
BackgroundThe accurate determination of age at onset (AAO) of Huntington's disease is critical to develop and evaluate therapies that aim to delay it.Aim(1) To compare the raters' estimates of AAO...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Neurology, Neurosurgery & Psychiatry
Paper Title
Journal
Date
